Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Chronic Pain 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Gene Expression × Clear all
NCT07169396 2025-09-11

GEN_EXP_CO2021

Azienda USL Reggio Emilia - IRCCS

Recruiting
180 enrolled
Gynecologic

Ovarian Neoplasms

NCT05507034 2023-12-27

sCANsens

Universiteit Antwerpen

Unknown
150 enrolled
Breast

Breast Neoplasms, Chronic Pain

NCT05493878 2022-08-09

ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer

Assiut University

Unknown
128 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02236546 2017-04-13

FDG-PET in Advanced Melanoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
3 enrolled 4 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡